A new paradigm in transplant immunology: At the crossroad of synthetic biology and biomaterials.

Zi-Jie Zhang, Lu-Yue Ding, Xiao-Lei Zuo, Hao Feng, Qiang Xia

Med (New York, N.Y.) 2023 Jul 14

filter terms:

Solid organ transplant (SOT) recipients require meticulously tailored immunosuppressive regimens to minimize graft loss and mortality. Traditional approaches focus on inhibiting effector T cells, while the intricate and dynamic immune responses mediated by other components remain unsolved. Emerging advances in synthetic biology and material science have provided novel treatment modalities with increased diversity and precision to the transplantation community. This review investigates the active interface between these two fields, highlights how living and non-living structures can be engineered and integrated for immunomodulation, and discusses their potential application in addressing the challenges in SOT clinical practice. Copyright © 2023 Elsevier Inc. All rights reserved.

Citation

Zi-Jie Zhang, Lu-Yue Ding, Xiao-Lei Zuo, Hao Feng, Qiang Xia. A new paradigm in transplant immunology: At the crossroad of synthetic biology and biomaterials. Med (New York, N.Y.). 2023 Jul 14;4(7):404-431